课题基金 / 基金详情

CORE--BIOMARKERS FACILITY

CORE--BIOMARKERS FACILITY
核心——生物标志物设施
批准号:
6336326
负责人:
Regina M Santella
金额:
$29.68万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2001-06-30

项目摘要

项目成果

Regina M Santella的其他基金

相似基金

相关文献

中文摘要
翻译
生物标志物设施提供了一个集中的,有效的,和成本- 用于接收、处理和储存人类样本的有效资源, 作为分子流行病学研究的一部分收集, 其他癌症相关研究。这些样本包括血液, 尿液和口腔细胞。机构收到编码样本, 加工成适当的级分(例如,血浆,淋巴细胞, 粒细胞、总白色血细胞、红血细胞)并冷冻在 尽可能将多份等分试样置于多个冰柜中。一 维持样本库存的计算机化数据库, 必要时进行分析。电话报警系统用于 确保样品安全和质量控制程序到位, 监控样品条件和数据库的准确性。
英文摘要
The Biomarkers Facility provides a centralized, efficient, and cost- effective resource for receiving, handling, and storing human samples that are collected as part of research studies in molecular epidemiology and other types of cancer related research. These samples include blood, urine, and buccal cells. Coded samples are received by the facility and processed into appropriate fractions (e.g., plasma, lymphocytes, granulocytes, total white blood cells, red blood cells) and frozen in multiple aliquots in more than one freezer whenever possible. A computerized data base of the sample inventory is maintained and samples retrieved for analysis when necessary. A telephone alarm system is used to ensure sample safety and quality control procedures are in place to monitor sample conditions and data base accuracy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MicroRNA in Blood as an Early Biomarker of Breast Cancer
MicroRNA in Blood as an Early Biomarker of Breast Cancer
CANCER EPIDEMIOLOGY RESEARCH
Exposure Assessment Facility/Service Cores
海外基金